Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,237 | -63,238 | -47,056 | -32,875 | -15,169 |
| Depreciation Amortization | 184 | 661 | 504 | 340 | 171 |
| Accounts payable and accrued liabilities | 1,490 | 221 | 518 | 57 | -266 |
| Other Working Capital | -4,393 | 33 | -2,067 | -3,364 | -4,659 |
| Other Operating Activity | 1,865 | 10,554 | 7,848 | 5,507 | 3,367 |
| Operating Cash Flow | $-27,091 | $-51,769 | $-40,253 | $-30,335 | $-16,556 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -556 | -24 | -24 | -24 | -24 |
| Investing Cash Flow | $-556 | $-24 | $-24 | $-24 | $-24 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 20,438 | 20,438 | 20,438 | 19,688 |
| Debt Repayment | N/A | -10,213 | -10,213 | -10,213 | -10,213 |
| Common Stock Issued | 120,006 | 50,703 | 351 | 198 | 198 |
| Common Stock Repurchased | -4,875 | -167 | N/A | N/A | N/A |
| Other Financing Activity | -190 | -683 | -683 | -683 | -546 |
| Financing Cash Flow | $114,941 | $60,078 | $9,893 | $9,740 | $9,127 |
| Exchange Rate Effect | -16 | -30 | -29 | -25 | -22 |
| Beginning Cash Position | 176,984 | 168,729 | 168,729 | 168,729 | 168,729 |
| End Cash Position | 264,262 | 176,984 | 138,316 | 148,085 | 161,254 |
| Net Cash Flow | $87,278 | $8,255 | $-30,413 | $-20,644 | $-7,475 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,091 | -51,769 | -40,253 | -30,335 | -16,556 |
| Capital Expenditure | -556 | -24 | -24 | -24 | -24 |
| Free Cash Flow | -27,647 | -51,793 | -40,277 | -30,359 | -16,580 |